Neuropeptide Y receptors Y1 and Y2 are present in neurons and glial cells in rat retinal cells in culture

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 1, 2013, Pages 429-443

  Santos Carvalho, Ana ^a,b   Aveleira, Célia A ^a   Elvas, Filipe ^c   Ambrósio, António Francisco ^a,c   Cavadas, Cláudia ^a,b  

^a UNIVERSITY OF COIMBRA   (Portugal)

^b UNIVERSITY OF COIMBRA   (Portugal)

^c UNIVERSITY OF COIMBRA   (Portugal)

Author keywords

[No Author keywords available]

Indexed keywords

CALBINDIN; CALCIUM BINDING PROTEIN; CALRETININ; CD11B ANTIGEN; MESSENGER RNA; NEUROPEPTIDE Y1 RECEPTOR; NEUROPEPTIDE Y2 RECEPTOR; PARVALBUMIN; RHODOPSIN; TRANSCRIPTION FACTOR POU4F1; VIMENTIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MICROGLIA; NERVE CELL CULTURE; NONHUMAN; PHOTORECEPTOR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RETINA GANGLION CELL; RETINA NERVE CELL;

ANIMALS; ANIMALS, NEWBORN; CELLS, CULTURED; IMMUNOHISTOCHEMISTRY; MICROGLIA; NEURONS; RATS; RATS, WISTAR; RECEPTORS, G-PROTEIN-COUPLED; RECEPTORS, NEUROPEPTIDE; RECEPTORS, NEUROPEPTIDE Y; RETINAL GANGLION CELLS; SIGNAL TRANSDUCTION;

EID: 84874719907     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.12-10776     Document Type: Article

References (118)

1. Michel MC, Beck-Sickinger A, Cox H, et al. XVI. International Union of Pharmacology recommendations for the nomenclature of neuropeptide Y, peptide YY, and pancreatic polypeptide receptors. Pharmacol Rev. 1998;50:143-150.
2. Tatemoto K, Carlquist M, Mutt V. Neuropeptide Y-a novel brain peptide with structural similarities to peptide YY and pancreatic polypeptide. Nature. 1982;296:659-660.
3. Silva AP, Xapelli S, Grouzmann E, Cavadas C. The putative neuroprotective role of neuropeptide Y in the central nervous system. Curr Drug Targets CNS Neurol Disord. 2005;4:331-347.
4. Wettstein JG, Earley B, Junien JL. Central nervous system pharmacology of neuropeptide Y. Pharmacol Ther. 1995;65: 397-414.
5. Xapelli S, Bernardino L, Ferreira R, et al. Interaction between neuropeptide Y (NPY) and brain-derived neurotrophic factor in NPY-mediated neuroprotection against excitotoxicity: a role for microglia. Eur J Neurosci. 2008;27:2089-2102.
6. Bruun A, Tornqvist K, Ehinger B. Neuropeptide Y (NPY) immunoreactive neurons in the retina of different species. Histochemistry. 1986;86:135-140.
7. Hiscock J, Straznicky C. Neuropeptide Y-like immunoreactive amacrine cells in the retina of Bufo marinus. Brain Res. 1989; 494:55-64.
8. Isayama T, Eldred WD. Neuropeptide Y-immunoreactive amacrine cells in the retina of the turtle Pseudemys scripta elegans. J Comp Neurol. 1988;271:56-66.
9. Jen PY, Li WW, Yew DT. Immunohistochemical localization of neuropeptide Y and somatostatin in human fetal retina. Neuroscience. 1994;60:727-735.
10. Mathieu M, Tagliafierro G, Bruzzone F, Vallarino M. Neuropeptide tyrosine-like immunoreactive system in the brain, olfactory organ and retina of the zebrafish, Danio rerio, during development. Brain Res Dev Brain Res. 2002;139: 255-265.
11. Oh SJ, D'Angelo I, Lee EJ, Chun MH, Brecha NC. Distribution and synaptic connectivity of neuropeptide Y-immunoreactive amacrine cells in the rat retina. J Comp Neurol. 2002;446: 219-234.
12. Osborne NN, Patel S, Terenghi G, Allen JM, Polak JM, Bloom SR. Neuropeptide Y (NPY)-like immunoreactive amacrine cells in retinas of frog and goldfish. Cell Tissue Res. 1985;241: 651-656.
13. Sinclair JR, Nirenberg S. Characterization of neuropeptide Yexpressing cells in the mouse retina using immunohistochemical and transgenic techniques. J Comp Neurol. 2001; 432:296-306.
14. Larhammar D, Blomqvist AG, Yee F, Jazin E, Yoo H, Wahlested C. Cloning and functional expression of a human neuropeptide Y/peptide YY receptor of the Y1 type. J Biol Chem. 1992;267:10935-10938.
15. Larhammar D, Salaneck E. Molecular evolution of NPY receptor subtypes. Neuropeptides. 2004;38:141-151.
16. Larsson TA, Olsson F, Sundstrom G, et al. Early vertebrate chromosome duplications and the evolution of the neuropeptide Y receptor gene regions. BMC Evol Biol. 2008;8:184.
17. Straznicky C, Hiscock J. Neuropeptide Y-like immunoreactivity in neurons of the human retina. Vision Res. 1989;29: 1041-1048.
18. Hutsler JJ, Chalupa LM. Neuropeptide Y immunoreactivity identifies a regularly arrayed group of amacrine cells within the cat retina. J Comp Neurol. 1994;346:481-489.
19. Hutsler JJ, Chalupa LM. Development of neuropeptide Y immunoreactive amacrine and ganglion cells in the pre-and postnatal cat retina. J Comp Neurol. 1995;361:152-164.
20. Chen S-T, Shen C-L, Wang J-P, Chou L-S. A Comparative Study of Neuropeptide Y-Immunoreactivity in the Retina of Dolphin and Several Other Mammalian Species. Zoological Studies. 1999;38:416-422.
21. Wetzel RK, Eldred WD. Specialized neuropeptide Y-and glucagon-like immunoreactive amacrine cells in the peripheral retina of the turtle. Vis Neurosci. 1997;14:867-877.
22. Zhu BS, Gibbins I. Muller cells in the retina of the cane toad, Bufo marinus, express neuropeptide Y-like immunoreactivity. Vis Neurosci. 1996;13:501-508.
23. Yoon HZ, Yan Y, Geng Y, Higgins RD. Neuropeptide Y expression in a mouse model of oxygen-induced retinopathy. Clin Experiment Ophthalmol. 2002;30:424-429.
24. Milenkovic I, Weick M, Wiedemann P, Reichenbach A, Bringmann A. Neuropeptide Y-evoked proliferation of retinal glial (Muller) cells. Graefes Arch Clin Exp Ophthalmol. 2004; 242:944-950.
25. Ammar DA, Hughes BA, Thompson DA. Neuropeptide Y and the retinal pigment epithelium: receptor subtypes, signaling, and bioelectrical responses. Invest Ophthalmol Vis Sci. 1998; 39:1870-1878.
26. Alvaro AR, Rosmaninho-Salgado J, Santiago AR, et al. NPY in rat retina is present in neurons, in endothelial cells and also in microglial and Muller cells. Neurochem Int. 2007;50:757-763.
27. D'Angelo I, Brecha NC. Y2 receptor expression and inhibition of voltage-dependent Ca2+ influx into rod bipolar cell terminals. Neuroscience. 2004;125:1039-1049.
28. D'Angelo I, Oh SJ, Chun MH, Brecha NC. Localization of neuropeptide Y1 receptor immunoreactivity in the rat retina and the synaptic connectivity of Y1 immunoreactive cells. J Comp Neurol. 2002;454:373-382.
29. Alvaro AR, Martins J, Araujo IM, Rosmaninho-Salgado J, Ambrosio AF, Cavadas C. Neuropeptide Y stimulates retinal neural cell proliferation-involvement of nitric oxide. J Neurochem. 2008;105:2501-2510.
30. Alvaro AR, Rosmaninho-Salgado J, Ambrosio AF, Cavadas C. Neuropeptide Y inhibits [Ca2+]i changes in rat retinal neurons through NPY Y1, Y4, and Y5 receptors. J Neurochem. 2009;109:1508-1515.
31. Alvaro AR, Martins J, Costa AC, et al. Neuropeptide Y protects retinal neural cells against cell death induced by ecstasy. Neuroscience. 2008;152:97-105.
32. Santiago AR, Pereira TS, Garrido MJ, Cristovao AJ, Santos PF, Ambrosio AF. High glucose and diabetes increase the release of [3H]-d-aspartate in retinal cell cultures and in rat retinas. Neurochemistry International. 2006;48:453-458.
33. Reis RA, Cabral da Silva MC, Loureiro dos Santos NE, et al. Sympathetic neuronal survival induced by retinal trophic factors. J Neurobiol. 2002;50:13-23.
34. Gunhan E, van der List D, Chalupa LM. Ectopic photoreceptors and cone bipolar cells in the developing and mature retina. J Neurosci. 2003;23:1383-1389.
35. Lameirao SV, Hamassaki DE, Rodrigues AR, SM DEL, Finlay BL, Silveira LC. Rod bipolar cells in the retina of the capuchin monkey (Cebus apella): characterization and distribution. Vis Neurosci. 2009;26:389-396.
36. Osborne NN, Barnett NL, Morris NJ, Huang FL. The occurrence of three isoenzymes of protein kinase C (alpha, beta and gamma) in retinas of different species. Brain Res. 1992;570:161-166.
37. Haverkamp S, Wassle H. Immunocytochemical analysis of the mouse retina. J Comp Neurol. 2000;424:1-23.
38. Hirano AA, Brandstatter JH, Morgans CW, Brecha NC. SNAP25 expression in mammalian retinal horizontal cells. J Comp Neurol. 2011;519:972-988.
39. Hwang IK, Yoo KY, Kim DS, et al. Comparative study on calretinin immunoreactivity in gerbil and rat retina. Anat Histol Embryol. 2005;34:129-131.
40. Kim SA, Jeon JH, Son MJ, Cha J, Chun MH, Kim IB. Changes in transcript and protein levels of calbindin D28k, calretinin and parvalbumin, and numbers of neuronal populations expressing these proteins in an ischemia model of rat retina. Anat Cell Biol. 2010;43:218-229.
41. Nadal-Nicolas FM, Jimenez-Lopez M, Sobrado-Calvo P, et al. Brn3a as a marker of retinal ganglion cells: qualitative and quantitative time course studies in naive and optic nerveinjured retinas. Invest Ophthalmol Vis Sci. 2009;50:3860-3868.
42. Xiang M, Zhou L, Macke JP, et al. The Brn-3 family of POUdomain factors: primary structure, binding specificity, and expression in subsets of retinal ganglion cells and somatosensory neurons. J Neurosci. 1995;15:4762-4785.
43. Schnitzer J. Immunocytochemical studies on the development of astrocytes, Muller (glial) cells, and oligodendrocytes in the rabbit retina. Brain Res Dev Brain Res. 1988;44:59-72.
44. Seth A, Cui J, To E, Kwee M, Matsubara J. Complementassociated deposits in the human retina. Invest Ophthalmol Vis Sci. 2008;49:743-750.
45. Costa GN, Vindeirinho J, Cavadas C, Ambrosio AF, Santos PF. Contribution of TNF receptor 1 to retinal neural cell death induced by elevated glucose. Mol Cell Neurosci. 2012;50: 113-123.
46. Gandorfer A, Rohleder M, Sethi C, et al. Posterior vitreous detachment induced by microplasmin. Invest Ophthalmol Vis Sci. 2004;45:641-647.
47. Kolesnikov AV, Rikimaru L, Hennig AK, et al. G-protein betagamma-complex is crucial for efficient signal amplification in vision. J Neurosci. 2011;31:8067-8077.
48. Cohen EE, Zhu H, Lingen MW, et al. A feed-forward loop involving protein kinase Calpha and microRNAs regulates tumor cell cycle. Cancer Res. 2009;69:65-74.
49. Zhang Q, Wang D, Kundumani-Sridharan V, et al. PLD1-dependent PKCgamma activation downstream to Src is essential for the development of pathologic retinal neovascularization. Blood. 2010;116:1377-1385.
50. Berger-Sweeney J, Stearns NA, Murg SL, Floerke-Nashner LR, Lappi DA, Baxter MG. Selective immunolesions of cholinergic neurons in mice: effects on neuroanatomy, neurochemistry, and behavior. J Neurosci. 2001;21:8164-8173.
51. Brzezinski JA IV, Kim EJ, Johnson JE, Reh TA. Ascl1 expression defines a subpopulation of lineage-restricted progenitors in the mammalian retina. Development. 2011; 138:3519-3531.
52. Cammas L, Trensz F, Jellali A, Ghyselinck NB, Roux MJ, Dolle P. Retinoic acid receptor (RAR)-alpha is not critically required for mediating retinoic acid effects in the developing mouse retina. Invest Ophthalmol Vis Sci. 2010;51:3281-3290.
53. Caprara C, Thiersch M, Lange C, Joly S, Samardzija M, Grimm C. HIF1A is essential for the development of the intermediate plexus of the retinal vasculature. Invest Ophthalmol Vis Sci. 2011;52:2109-2117.
54. Cho YJ, Lee JC, Kang BG, et al. Immunohistochemical study on the expression of calcium binding proteins (calbindin-D28k, calretinin, and parvalbumin) in the cerebral cortex and in the hippocampal region of nNOS knock-out(-/-) mice. Anat Cell Biol. 2011;44:106-115.
55. de Melo J, Qiu X, Du G, Cristante L, Eisenstat DD. Dlx1, Dlx2, Pax6, Brn3b, and Chx10 homeobox gene expression defines the retinal ganglion and inner nuclear layers of the developing and adult mouse retina. J Comp Neurol. 2003; 461:187-204.
56. Gallagher SK, Witkovsky P, Roux MJ, et al. beta-Endorphin expression in the mouse retina. J Comp Neurol. 2010;518: 3130-3148.
57. Joly S, Lange C, Thiersch M, Samardzija M, Grimm C. Leukemia inhibitory factor extends the lifespan of injured photoreceptors in vivo. J Neurosci. 2008;28:13765-13774.
58. Kim BJ, Lee SY, Kim HW, et al. Optimized immunohistochemical analysis of cerebellar purkinje cells using a specific biomarker, calbindin d28k. Korean J Physiol Pharmacol. 2009;13:373-378.
59. Lee JC, Chung YH, Cho YJ, et al. Immunohistochemical study on the expression of calcium binding proteins (calbindin-D28k, calretinin, and parvalbumin) in the cerebellum of the nNOS knock-out(-/-) mice. Anat Cell Biol. 2010;43:64-71.
60. Matilla A, Gorbea C, Einum DD, et al. Association of ataxin-7 with the proteasome subunit S4 of the 19S regulatory complex. Hum Mol Genet. 2001;10:2821-2831.
61. Baizer JS, Baker JF. Immunoreactivity for calcium-binding proteins defines subregions of the vestibular nuclear complex of the cat. Exp Brain Res. 2005;164:78-91.
62. Bender RA, Lauterborn JC, Gall CM, Cariaga W, Baram TZ. Enhanced CREB phosphorylation in immature dentate gyrus granule cells precedes neurotrophin expression and indicates a specific role of CREB in granule cell differentiation. Eur J Neurosci. 2001;13:679-686.
63. Liu F, You Y, Li X, et al. Brain injury does not alter the intrinsic differentiation potential of adult neuroblasts. J Neurosci. 2009;29:5075-5087.
64. Pinzon-Duarte G, Daly G, Li YN, Koch M, Brunken WJ. Defective formation of the inner limiting membrane in laminin beta2-and gamma3-null mice produces retinal dysplasia. Invest Ophthalmol Vis Sci. 2010;51:1773-1782.
65. Perrotti LI, Hadeishi Y, Ulery PG, et al. Induction of deltaFosB in reward-related brain structures after chronic stress. J Neurosci. 2004;24:10594-10602.
66. Runyan CA, Schummers J, Van Wart A, et al. Response features of parvalbumin-expressing interneurons suggest precise roles for subtypes of inhibition in visual cortex. Neuron. 2010;67:847-857.
67. Kroehne V, Freudenreich D, Hans S, Kaslin J, Brand M. Regeneration of the adult zebrafish brain from neurogenic radial glia-type progenitors. Development. 2011;138:4831-4841.
68. D'Autreaux F, Coppola E, Hirsch MR, Birchmeier C, Brunet JF. Homeoprotein Phox2b commands a somatic-to-visceral switch in cranial sensory pathways. Proceedings of the National Academy of Sciences of the United States of America. 2011;108:20018-20023.
69. Alunni A, Vaccari S, Torcia S, Meomartini ME, Nicotra A, Alfei L. Characterization of glial fibrillary acidic protein and astroglial architecture in the brain of a continuously growing fish, the rainbow trout. Eur J Histochem. 2005;49:157-166.
70. Ruiz-Ederra J, Hitchcock PF, Vecino E. Two classes of astrocytes in the adult human and pig retina in terms of their expression of high affinity NGF receptor (TrkA). Neurosci Lett. 2003;337:127-130.
71. Burgi S, Samardzija M, Grimm C. Endogenous leukemia inhibitory factor protects photoreceptor cells against lightinduced degeneration. Mol Vis. 2009;15:1631-1637.
72. Chew SS, Johnson CS, Green CR, Danesh-Meyer HV. Response of retinal Connexin43 to optic nerve injury. Invest Ophthalmol Vis Sci. 2011;52:3620-3629.
73. Morales-Garcia JA, Redondo M, Alonso-Gil S, et al. Phosphodiesterase 7 inhibition preserves dopaminergic neurons in cellular and rodent models of Parkinson disease. PLoS One. 2011;6:e17240.
74. Robinson AP, White TM, Mason DW. Macrophage heterogeneity in the rat as delineated by two monoclonal antibodies MRC OX-41 and MRC OX-42, the latter recognizing complement receptor type 3. Immunology. 1986;57:239-247.
75. Spencer-Segal JL, Waters EM, Bath KG, Chao MV, McEwen BS, Milner TA. Distribution of phosphorylated TrkB receptor in the mouse hippocampal formation depends on sex and estrous cycle stage. J Neurosci. 2011;31:6780-6790.
76. Snow RL, Robson JA. Migration and differentiation of neurons in the retina and optic tectum of the chick. Exp Neurol. 1995;134:13-24.
77. Heanue TA, Pachnis V. Prospective identification and isolation of enteric nervous system progenitors using Sox2. Stem cells (Dayton, Ohio). 2011;29:128-140.
78. Kunath T, Saba-El-Leil MK, Almousailleakh M, Wray J, Meloche S, Smith A. FGF stimulation of the Erk1/2 signalling cascade triggers transition of pluripotent embryonic stem cells from self-renewal to lineage commitment. Development. 2007;134:2895-2902.
79. Mak SK, Huang YA, Iranmanesh S, et al. Small molecules greatly improve conversion of human-induced pluripotent stem cells to the neuronal lineage. Stem Cells Int. 2012;2012: 140427.
80. Vazquez P, Arroba AI, Cecconi F, de la Rosa EJ, Boya P, de Pablo F. Atg5 and Ambra1 differentially modulate neurogenesis in neural stem cells. Autophagy. 2012;8:187-199.
81. Du J, Campau E, Soragni E, et al. Role of mismatch repair enzymes in GAA{middle dot}TTC Triplet-repeat expansion in friedreich ataxia induced pluripotent stem cells. J Biol Chem. 2012;287:29861-29872.
82. Jeon HM, Sohn YW, Oh SY, et al. ID4 imparts chemoresistance and cancer stemness to glioma cells by derepressing miR-9*-mediated suppression of SOX2. Cancer Res. 2011;71: 3410-3421.
83. Lemmon V, Rieser G. The development distribution of vimentin in the chick retina. Brain Res. 1983;313:191-197.
84. Chen X, Kang H, Zou F. Low concentration of GA activates a preconditioning response in HepG2 cells during oxidative stress-roles of Hsp90 and vimentin. Cell Stress Chaperones. 2009;14:381-389.
85. Helboe L, Moller M. Immunohistochemical localization of somatostatin receptor subtypes sst1 and sst2 in the rat retina. Invest Ophthalmol Vis Sci. 1999;40:2376-2382.
86. Baptista S, Bento AR, Goncalves J, et al. Neuropeptide Y promotes neurogenesis and protection against methamphetamine-induced toxicity in mouse dentate gyrus-derived neurosphere cultures. Neuropharmacology. 2012;62:2413-2423.
87. Ferreira R, Xapelli S, Santos T, et al. Neuropeptide Y modulation of interleukin-1 beta (IL-1{beta})-induced nitric oxide production in microglia. J Biol Chem. 2010;285: 41921-41934.
88. Bruun A, Ehinger B, Ekman R. Characterization of neuropeptide Y-like immunoreactivity in vertebrate retina. Exp Eye Res. 1991;53:539-543.
89. Tornqvist K, Ehinger B. Peptide immunoreactive neurons in the human retina. Invest Ophthalmol Vis Sci. 1988;29:680-686.
90. Negishi K, Kiyama H, Kato S, et al. An immunohistochemical study on the river lamprey retina. Brain Res. 1986;362:389-393.
91. Osborne NN, Beaton DW, Boyd PJ, Walker RJ. Substance Plike immunoreactivity in the retina and optic lobe of the squid. Neurosci Lett. 1986;70:65-68.
92. Straznicky C, Hiscock J. Neuropeptide Y-immunoreactive neurons in the retina of two Australian lizards. Arch Histol Cytol. 1994;57:151-160.
93. Isayama T, Polak J, Eldred WD. Synaptic analysis of amacrine cells with neuropeptide Y-like immunoreactivity in turtle retina. J Comp Neurol. 1988;275:452-459.
94. Hiscock J, Straznicky C. Neuropeptide Y-and substance P-like immunoreactive amacrine cells in the retina of the developing Xenopus laevis. Brain Res Dev Brain Res. 1990;54:105-113.
95. Silva AP, Pinheiro PS, Carvalho AP, et al. Activation of neuropeptide Y receptors is neuroprotective against excitotoxicity in organotypic hippocampal slice cultures. FASEB J. 2003;17:1118-1120.
96. Decressac M, Pain S, Chabeauti PY, et al. Neuroprotection by neuropeptide Y in cell and animal models of Parkinson's disease. Neurobiol Aging. 2012;332125-2137.
97. Smialowska M, Domin H, Zieba B, et al. Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo. Neuropeptides. 2009;43:235-249.
98. Xapelli S, Silva AP, Ferreira R, Malva JO. Neuropeptide Y can rescue neurons from cell death following the application of an excitotoxic insult with kainate in rat organotypic hippocampal slice cultures. Peptides. 2007;28:288-294.
99. Doyle KL, Hort YJ, Herzog H, Shine J. Neuropeptide Y and peptide YY have distinct roles in adult mouse olfactory neurogenesis. J Neurosci Res. 2012;90:1126-1135.
100. Thiriet N, Agasse F, Nicoleau C, et al. NPY promotes chemokinesis and neurogenesis in the rat subventricular zone. J Neurochem. 2011;116:1018-1027.
101. Son MY, Kim MJ, Yu K, Koo DB, Cho YS. Involvement of neuropeptide Y and its Y1 and Y5 receptors in maintaining self-renewal and proliferation of human embryonic stem cells. J Cell Mol Med. 2011;15:152-165.
102. Sinclair JR, Jacobs AL, Nirenberg S. Selective ablation of a class of amacrine cells alters spatial processing in the retina. J Neurosci. 2004;24:1459-1467.
103. Bruun A, Ehinger B. NPY-induced neurotransmitter release from the rabbit and chicken retina. Acta Ophthalmol (Copenh) 1993;71:590-596.
104. Canto Soler MV, Gallo JE, Dodds RA, Hokfelt T, Villar MJ, Suburo AM. Y1 receptor of neuropeptide Y as a glial marker in proliferative vitreoretinopathy and diseased human retina. Glia. 2002;39:320-324.
105. Agasse F, Bernardino L, Kristiansen H, et al. Neuropeptide Y Promotes Neurogenesis in Murine Subventricular Zone. Stem Cells (Dayton, Ohio). 2008;26:1636-1645.
106. Decressac M, Wright B, David B, et al. Exogenous neuropeptide Y promotes in vivo hippocampal neurogenesis. Hippocampus. 2011;21:233-238.
107. Hansel DE, Eipper BA, Ronnett GV. Regulation of olfactory neurogenesis by amidated neuropeptides. J Neurosci Res. 2001;66:1-7.
108. Howell OW, Scharfman HE, Herzog H, Sundstrom LE, Beck-Sickinger A, Gray WP. Neuropeptide Y is neuroproliferative for post-natal hippocampal precursor cells. J Neurochem. 2003;86:646-659.
109. Rodrigo C, Zaben M, Lawrence T, Laskowski A, Howell OW, Gray WP. NPY augments the proliferative effect of FGF2 and increases the expression of FGFR1 on nestin positive postnatal hippocampal precursor cells, via the Y1 receptor. J Neurochem. 2010;113:615-627.
110. Stanic D, Paratcha G, Ledda F, Herzog H, Kopin AS, Hokfelt T. Peptidergic influences on proliferation, migration, and placement of neural progenitors in the adult mouse forebrain. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:3610-3615.
111. Langmann T. Microglia activation in retinal degeneration. J Leukoc Biol. 2007;81:1345-1351.
112. Wang M, Ma W, Zhao L, Fariss RN, Wong WT. Adaptive Muller cell responses to microglial activation mediate neuroprotection and coordinate inflammation in the retina. J Neuroinflammation. 2011;8:173.
113. Bedoui S, Kawamura N, Straub RH, Pabst R, Yamamura T, von Horsten S. Relevance of neuropeptide Y for the neuroimmune crosstalk. J Neuroimmunol. 2003;134:1-11.
114. Ferreira R, Santos T, Cortes L, et al. Neuropeptide Y inhibits interleukin-1 beta-induced microglia motility. J Neurochem. 2012;120:93-105.
115. Ferreira R, Santos T, Viegas M, et al. Neuropeptide Y inhibits interleukin-1beta-induced phagocytosis by microglial cells. J Neuroinflammation. 2011;8:169.
116. Jacques D, Sader S, Perreault C, Abdel-Samad D, Jules F, Provost C. NPY, ET-1, and Ang II nuclear receptors in human endocardial endothelial cells. Can J Physiol Pharmacol. 2006;84:299-307.
117. Valdehita A, Bajo AM, Fernandez-Martinez AB, et al. Nuclear localization of vasoactive intestinal peptide (VIP) receptors in human breast cancer. Peptides. 2010;31:2035-2045.
118. Jacques D, Sader S, Perreault C, et al. Presence of neuropeptide Y and the Y1 receptor in the plasma membrane and nuclear envelope of human endocardial endothelial cells: modulation of intracellular calcium. Can J Physiol Pharmacol. 2003;81:288-300.